Repaglinide
NDC 72603-812, Repaglinide, tablet, from NorthStar RxLLC.
- Product NDC
- 72603-812
- Status
- Listed
- Labeler
- NorthStar RxLLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207209
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72603-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPAGLINIDE2 mg/1
Pharmacologic classes
Glinide [EPC]; Potassium Channel Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72603-812-01 | 72603081201 | 100 TABLET in 1 BOTTLE (72603-812-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665NADAC price for package 72603081201
GET /v1/drugs/nadac/72603081201
Use it
Look up 72603-812 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72603-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72603-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.